The Real Reason Pfizer Wanted Allergan Becomes Abundantly Clear
Pfizer's decision to walk away from Allergan tells investors that its interest was always tied more to the tax savings than it was to Allergan's products and pipeline.
This podcast was recorded on Apr. 6, 2016.